Boaz Musafia

Boaz Musafia has extensive work experience in the biotechnology and pharmaceutical industries. Boaz began their career at Darley Pharmaceuticals in 2004 as the Head of Research and Acting CSO, where they stayed until 2007. Boaz then joined EPIX Pharmaceuticals as an Associate Director in 2007. In 2009, Boaz served as the Director of Drug Development at O.D.A. In 2010, they became the CTO of Bio-Vent Ltd. and remained in that role until 2013. Boaz then worked as a Senior Scientist at Aptatek from 2013 to 2014. From 2014 to 2017, Boaz managed a collaborative biorepository for research called MIDGAM - Israel Collaborative Biorepository for Research. In 2017, they joined EVchip as the Executive Director of Innovation. Boaz then became the VP of R&D at CANNASOUL ANALYTICS LTD from 2018 to 2023. Currently, Boaz is a Product Manager at Evogene, starting in 2023.

Boaz Musafia has an extensive education history in the field of biology and molecular modeling. Boaz first attended Tel Aviv University from 1991 to 1996, where they obtained a Ph.D in Structural Biology and Molecular Modeling. Prior to this, Boaz completed their M.Sc at Technion - Israel Institute of Technology from 1987 to 1990, with a focus on Molecular Biology, Genetics, and Protein Engineering. Boaz also earned a BSc in Biology from Technion in 1985. In addition, Boaz briefly studied at Tel Aviv University in 1984, where they pursued a BSc in Biology. Though details are not provided, it is mentioned that they also completed a Master of Science (MS) degree at Technion, but the specific field of study is not mentioned.